These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 1702747)
21. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Simpson KL; Holmes CH Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850 [TBL] [Abstract][Full Text] [Related]
23. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack. Marchbank KJ; Morgan BP; van den Berg CW Immunology; 1995 May; 85(1):146-52. PubMed ID: 7543447 [TBL] [Abstract][Full Text] [Related]
24. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. Tedesco F; Narchi G; Radillo O; Meri S; Ferrone S; Betterle C J Immunol; 1993 Aug; 151(3):1562-70. PubMed ID: 7687635 [TBL] [Abstract][Full Text] [Related]
25. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Clayton A; Harris CL; Court J; Mason MD; Morgan BP Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951 [TBL] [Abstract][Full Text] [Related]
26. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264 [TBL] [Abstract][Full Text] [Related]
27. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis. Matsumoto M; Sugita Y; Seya T Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391 [TBL] [Abstract][Full Text] [Related]
28. Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor. Lederman MM; Purvis SF; Walter EI; Carey JT; Medof ME Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4205-9. PubMed ID: 2471198 [TBL] [Abstract][Full Text] [Related]
30. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Nose M; Katoh M; Okada N; Kyogoku M; Okada H Immunology; 1990 Jun; 70(2):145-9. PubMed ID: 1695609 [TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986 [TBL] [Abstract][Full Text] [Related]
32. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Hakulinen J; Meri S Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of the complement regulatory proteins in the human eye. Bora NS; Gobleman CL; Atkinson JP; Pepose JS; Kaplan HJ Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3579-84. PubMed ID: 7505007 [TBL] [Abstract][Full Text] [Related]
34. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59. Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913 [TBL] [Abstract][Full Text] [Related]
35. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Marschang P; Sodroski J; Würzner R; Dierich MP Eur J Immunol; 1995 Jan; 25(1):285-90. PubMed ID: 7531147 [TBL] [Abstract][Full Text] [Related]
36. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. Davies A; Simmons DL; Hale G; Harrison RA; Tighe H; Lachmann PJ; Waldmann H J Exp Med; 1989 Sep; 170(3):637-54. PubMed ID: 2475570 [TBL] [Abstract][Full Text] [Related]
37. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Tandon N; Morgan BP; Weetman AP Immunology; 1992 Feb; 75(2):372-7. PubMed ID: 1372592 [TBL] [Abstract][Full Text] [Related]
38. Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic follicles. Lampert IA; Schofield JB; Amlot P; Van Noorden S J Pathol; 1993 Jun; 170(2):115-20. PubMed ID: 7688416 [TBL] [Abstract][Full Text] [Related]
39. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland. Bardenstein DS; Dietz Y; Lass JH; Medof ME Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649 [TBL] [Abstract][Full Text] [Related]
40. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis. Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]